Samuel Frank

4.9k total citations
92 papers, 2.0k citations indexed

About

Samuel Frank is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Samuel Frank has authored 92 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Cellular and Molecular Neuroscience, 48 papers in Neurology and 18 papers in Molecular Biology. Recurrent topics in Samuel Frank's work include Genetic Neurodegenerative Diseases (47 papers), Neurological disorders and treatments (43 papers) and Parkinson's Disease Mechanisms and Treatments (21 papers). Samuel Frank is often cited by papers focused on Genetic Neurodegenerative Diseases (47 papers), Neurological disorders and treatments (43 papers) and Parkinson's Disease Mechanisms and Treatments (21 papers). Samuel Frank collaborates with scholars based in United States, United Kingdom and Israel. Samuel Frank's co-authors include Vernon L. Towle, Robert Grzeszczuk, Raif Çakmur, Jean‐Paul Spire, David Levin, Kim K. Tan, Robert G. Holloway, Scott Y. H. Kim, Joseph Jankovic and Eve Van Cauter and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and American Journal of Epidemiology.

In The Last Decade

Samuel Frank

86 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel Frank United States 21 745 743 511 365 282 92 2.0k
Ting Wu China 26 295 0.4× 552 0.7× 341 0.7× 334 0.9× 453 1.6× 118 2.4k
David P. Breen United Kingdom 26 1.7k 2.3× 407 0.5× 598 1.2× 390 1.1× 422 1.5× 52 2.7k
Claudio Lucetti Italy 32 1.1k 1.5× 354 0.5× 348 0.7× 250 0.7× 293 1.0× 74 2.4k
Elsmarieke van de Giessen Netherlands 22 333 0.4× 705 0.9× 521 1.0× 255 0.7× 317 1.1× 85 2.0k
Kathleen L. Poston United States 30 1.6k 2.1× 608 0.8× 639 1.3× 212 0.6× 525 1.9× 108 2.8k
Elizabeth McCusker Australia 22 936 1.3× 1.1k 1.5× 227 0.4× 576 1.6× 341 1.2× 44 2.1k
Francesca Trojsi Italy 31 1.2k 1.6× 284 0.4× 437 0.9× 264 0.7× 345 1.2× 122 2.7k
Diego Iacono United States 25 796 1.1× 366 0.5× 640 1.3× 301 0.8× 589 2.1× 64 2.2k
Carlos Singer United States 32 2.8k 3.7× 1.1k 1.5× 374 0.7× 391 1.1× 400 1.4× 134 3.8k
Caroline Hommet France 25 452 0.6× 392 0.5× 701 1.4× 306 0.8× 471 1.7× 106 2.4k

Countries citing papers authored by Samuel Frank

Since Specialization
Citations

This map shows the geographic impact of Samuel Frank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Frank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Frank more than expected).

Fields of papers citing papers by Samuel Frank

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Frank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Frank. The network helps show where Samuel Frank may publish in the future.

Co-authorship network of co-authors of Samuel Frank

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Frank. A scholar is included among the top collaborators of Samuel Frank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Frank. Samuel Frank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frank, Samuel, et al.. (2025). Unraveling progressive verbal memory deficits in Huntington’s disease: insights from the LASSI-L. Frontiers in Neurology. 16. 1494816–1494816.
2.
Frank, Samuel, et al.. (2025). Suicidal Ideation and Sleep Disturbances Among People With Huntington Disease. Neurology Clinical Practice. 15(3). e200461–e200461. 1 indexed citations
3.
Frank, Samuel, Jody Goldstein, Elise Kayson, et al.. (2025). Safety and Efficacy of Deutetrabenazine at High versus Lower Daily Dosages in the ARC-HD Study to Treat Chorea in Huntington Disease. CNS Drugs. 39(2). 185–195. 1 indexed citations
4.
Considine, Ciaran, Clare M. Eddy, Samuel Frank, et al.. (2025). Improving the Clinical Diagnostic Criteria for Genetically Confirmed Adult-Onset Huntington Disease. Neurology Clinical Practice. 15(2). e200427–e200427. 2 indexed citations
5.
O’Shea, Sarah A., et al.. (2024). Obesity and the development of Parkinson’s disease within the Framingham Heart study cohort. Clinical Parkinsonism & Related Disorders. 12. 100291–100291. 1 indexed citations
6.
Schubert, Robin, et al.. (2023). LASSI-L detects early cognitive changes in pre-motor manifest Huntington’s disease: a replication and validation study. Frontiers in Neurology. 14. 1191718–1191718. 4 indexed citations
7.
Frank, Samuel, et al.. (2023). Using the LASSI-L to Detect Robust Interference Effects in Premanifest Huntington Disease. Cognitive and Behavioral Neurology. 36(2). 100–107. 3 indexed citations
8.
Frank, Samuel, et al.. (2023). Clinical Utility of Deutetrabenazine as a Treatment Option for Chorea Associated with Huntington’s Disease and Tardive Dyskinesia. Therapeutics and Clinical Risk Management. Volume 19. 1019–1024. 3 indexed citations
9.
10.
Luo, Lan, Howard Andrews, Roy N. Alcalay, et al.. (2019). Motor phenotype classification in moderate to advanced PD in BioFIND study. Parkinsonism & Related Disorders. 65. 178–183. 20 indexed citations
11.
Frank, Samuel, Laura Diaz Hernandez, Penelope Hogarth, et al.. (2019). Transportation innovation to aid Parkinson disease trial recruitment. Contemporary Clinical Trials Communications. 16. 100449–100449. 7 indexed citations
12.
Carlozzi, Noelle E., S. Schilling, Anna L. Kratz, et al.. (2018). Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability?. Quality of Life Research. 27(10). 2541–2555. 14 indexed citations
13.
Johnson, Margaret, et al.. (2017). Utilization of Hospice Services in a Population of Patients With Huntington's Disease. Journal of Pain and Symptom Management. 55(2). 440–443. 17 indexed citations
14.
Goldman, Jennifer G., Howard Andrews, Amy W. Amara, et al.. (2017). Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features. Movement Disorders. 33(2). 282–288. 117 indexed citations
15.
Carlozzi, Noelle E., Elizabeth A. Hahn, Siera Goodnight, et al.. (2017). Patient-reported outcome measures in Huntington disease: Quality of life in neurological disorders (Neuro-QoL) social functioning measures.. Psychological Assessment. 30(4). 450–458. 11 indexed citations
16.
Frank, Samuel, et al.. (2012). Botulinum Toxin for Painful Spasms From Focal Seizures. The Neurologist. 19(1). 15–16. 3 indexed citations
17.
Frank, Samuel & Joseph Jankovic. (2010). Advances in the Pharmacological Management of Huntingtonʼs Disease. Drugs. 70(5). 561–571. 48 indexed citations
18.
19.
Kim, Scott Y. H., Robert G. Holloway, Samuel Frank, Renée Wilson, & Karl Kieburtz. (2008). Trust in early phase research: therapeutic optimism and protective pessimism. Medicine Health Care and Philosophy. 11(4). 393–401. 5 indexed citations
20.
Towle, Vernon L., Kim K. Tan, Robert Grzeszczuk, et al.. (1993). The spatial location of EEG electrodes: locating the best-fitting sphere relative to cortical anatomy. Electroencephalography and Clinical Neurophysiology. 86(1). 1–6. 349 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ting Wu Breakdown of academic impact, for papers by David P. Breen Breakdown of academic impact, for papers by Claudio Lucetti Breakdown of academic impact, for papers by Elsmarieke van de Giessen Breakdown of academic impact, for papers by Kathleen L. Poston Breakdown of academic impact, for papers by Elizabeth McCusker Breakdown of academic impact, for papers by Francesca Trojsi Breakdown of academic impact, for papers by Diego Iacono Breakdown of academic impact, for papers by Carlos Singer Breakdown of academic impact, for papers by Caroline Hommet
Rankless by CCL
2026